JPH0645531B2 - External skin preparation - Google Patents

External skin preparation

Info

Publication number
JPH0645531B2
JPH0645531B2 JP60056489A JP5648985A JPH0645531B2 JP H0645531 B2 JPH0645531 B2 JP H0645531B2 JP 60056489 A JP60056489 A JP 60056489A JP 5648985 A JP5648985 A JP 5648985A JP H0645531 B2 JPH0645531 B2 JP H0645531B2
Authority
JP
Japan
Prior art keywords
dimethylethyl
skin
branched
present
unsaturated alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60056489A
Other languages
Japanese (ja)
Other versions
JPS61215316A (en
Inventor
威 柳田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60056489A priority Critical patent/JPH0645531B2/en
Publication of JPS61215316A publication Critical patent/JPS61215316A/en
Publication of JPH0645531B2 publication Critical patent/JPH0645531B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は4−(1,1−ジメチルエチル)−4′−メト
キシジベンゾイルメタンとともに、炭素数9ないし31
の直鎖、分岐、不飽和アルキル残基を持つ1価のアルコ
ールと炭素数9ないし31の直鎖、分岐、不飽和アルキ
ル残基を持つ酸との1価のエステルを配合することによ
り優れた紫外線防御効果と、すぐれた品質をもつ皮膚外
用剤に関するものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention relates to 4- (1,1-dimethylethyl) -4′-methoxydibenzoylmethane together with a carbon number of 9 to 31.
By blending a monovalent alcohol having a straight chain, branched chain or unsaturated alkyl residue with a monovalent ester of an acid having a straight chain, branched chain or unsaturated alkyl residue having 9 to 31 carbon atoms. The present invention relates to a skin external preparation having an ultraviolet protection effect and excellent quality.

[従来の技術] 太陽光線は日焼けをおこすばかりか、その日焼けのため
に皮膚の老化を促進することが知られている。
[Prior Art] It is known that sun rays not only cause sunburn but also promote skin aging due to the sunburn.

太陽光線を防ぐように配慮された皮膚外用剤はすくなく
ないが、そのいずれもが粉末を配合して主として反射、
散乱によって対処したもの、あるいはUV−Bとよばれ
る比較的波長の短かい紫外線のみを吸収するサリチル酸
誘導体、アミノ安息香酸誘導体のような物質を配合した
ものであった。
There are not a few skin external preparations designed to prevent the sun's rays, but all of them are powdered and mainly reflected,
It was dealt with by scattering, or was compounded with substances called UV-B such as salicylic acid derivatives and aminobenzoic acid derivatives that absorb only ultraviolet rays having a relatively short wavelength.

[発明が解決しようとする問題点] 4−(1,1−ジメチルエチル)−4′−メトキシジベ
ンゾイルメタンは太陽光線、特に皮膚に対して有害なU
V−Aとよばれる比較的長波長の紫外線を吸収する物質
として近年脚光をあびているが、皮膚外用剤基剤との相
溶性が悪く、溶解状態で皮膚外用剤に配合しても比較的
短時間のうちに結晶として析出してしまうことが多い。
[Problems to be Solved by the Invention] 4- (1,1-Dimethylethyl) -4′-methoxydibenzoylmethane is a harmful U to sun rays, especially to the skin.
Recently, it has been spotlighted as a substance called VA that absorbs ultraviolet rays having a relatively long wavelength, but its compatibility with the skin external preparation base is poor, and it is relatively short even if it is mixed with the skin external preparation in a dissolved state. It often precipitates as crystals over time.

結晶として析出した場合は皮膚外用剤の品質を著しく損
ねることは言うまでもなく、本来の目的の紫外線吸収能
さえも発揮できない状態となってしまう。
Needless to say, when the crystals are deposited as crystals, the quality of the external preparation for skin is significantly impaired, and even the UV absorption ability for the original purpose cannot be exhibited.

[問題点を解決するための手段] 本発明者は係る事情に鑑み鋭意研究の結果、4−(1,
1−ジメチルエチル)−4′−メトキシジベンゾイルメ
タンとともに、炭素数9ないし31の直鎖、分岐、不飽
和アルキル残基を持つ1価のアルコールと炭素数9ない
し31の直鎖、分岐、不飽和アルキル残基を持つ酸との
1価のエステルを配合すれば、紫外線吸収効果に優れる
ことはもちろん、長期間安定性に優れ品質劣化をおこす
ことのすくない皮膚外用剤を得られることを見出し本発
明を完成するに至った。
[Means for Solving Problems] As a result of earnest research in view of such circumstances, the present inventor has found that 4- (1,
1-Dimethylethyl) -4'-methoxydibenzoylmethane together with a monohydric alcohol having a C9-C31 straight-chain, branched, or unsaturated alkyl residue and a C9-C31 straight-chain, branched, C1-C3 It has been found that by adding a monovalent ester with an acid having a saturated alkyl residue, it is possible to obtain an external preparation for skin which is excellent in ultraviolet absorbing effect and is excellent in stability for a long period of time and does not easily deteriorate in quality. The invention was completed.

すなわち本発明は優れた紫外線吸収効果、優れた品質を
もつ皮膚外用剤を提供するものである。
That is, the present invention provides a skin external preparation having an excellent ultraviolet absorbing effect and an excellent quality.

以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be described in detail.

本発明で用いられる4−(1,1−ジメチルエチル)−
4′−メトキシジベンゾイルメタンは、特開昭55−6
6535に示される方法で製造され、ジボダン株式会社
より「パルソール1789」の商品名で供給されてい
る。
4- (1,1-dimethylethyl) -used in the present invention
4'-methoxydibenzoylmethane is disclosed in JP-A-55-6.
It is manufactured by the method shown in 6535, and is supplied by Givaudan Co., Ltd. under the trade name of "Pulsol 1789".

皮膚外用剤に配合する量としては期待する紫外線吸収効
果に大じて任意であるが、極端に配合量が多い場合に
は、皮膚外用剤基剤の分量がすくなくなり、好ましくな
い。好ましくは0.01〜10%である。0.01%以
下では紫外線吸収効果が少なく本来の目的を発揮でき
ず、10%を越える場合には皮膚外用基剤の分量が減り
皮膚外用剤そのものとしての品質が損なわれる。
The amount to be added to the external preparation for skin is largely arbitrary depending on the expected UV absorption effect, but if the amount is extremely large, the base of the external preparation for skin becomes too small, which is not preferable. It is preferably 0.01 to 10%. If it is less than 0.01%, the ultraviolet absorbing effect is small and the intended purpose cannot be achieved. If it exceeds 10%, the amount of the base for external skin application is reduced and the quality of the external skin preparation itself is impaired.

また本発明の効果を発揮する目的で配合される炭素数9
ないし31の直鎖、分岐、不飽和アルキル残基を持つ1
価のアルコールと炭素数9ないし31の直鎖、分岐、不
飽和アルキル残基を持つ酸との1価のエステルとして
は、たとえば2−ヘキシルデシルミリステート、2−オ
クチルドデシル−2′−イソヘプチルイソウンデカノエ
ート、オレイルオレート、2−ヘプチルウンデシルパル
ミテート等の合成油、あるいは植物油のホホバオイル、
深海魚油のオレンジラフィー油、ビースワックスなどの
天然油などがある、 これらのエステルを一種または二種以上配合するが、本
発明の効果を発揮する目的で配合される量としては4−
(1,1−ジメチルエチル)−4′−メトキシジベンゾ
イルメタンの量に対して1/2以上が必要であり、過剰
に配合しても本発明の効果を阻害するものではない。
Further, the number of carbon atoms to be blended for the purpose of exerting the effect of the present invention is 9
1 to having 1 to 31 straight chain, branched chain, unsaturated alkyl residues
Examples of the monovalent ester of a divalent alcohol and an acid having a linear, branched or unsaturated alkyl residue having 9 to 31 carbon atoms include 2-hexyldecyl myristate and 2-octyldodecyl-2'-isoheptyl. Synthetic oils such as isoundecanoate, oleyl oleate, 2-heptylundecyl palmitate, or vegetable oil jojoba oil,
Deep sea fish oil such as orange luffy oil and natural oils such as beeswax are included. One or more of these esters are blended, but the amount blended for the purpose of exerting the effect of the present invention is 4-
The amount of (1,1-dimethylethyl) -4'-methoxydibenzoylmethane is required to be 1/2 or more, and even if it is added in excess, the effect of the present invention is not impaired.

本発明において4−(1,1−ジメチルエチル)−4′
−メトキシジベンゾイルメタンと炭素数9ないし31の
直鎖、分岐、不飽和アルキル残基を持つ1価のアルコー
ルと炭素数9ないし31の直鎖、分岐、不飽和アルキル
残基を持つ酸との1価のエステルを配合される皮膚外用
剤基剤としては通常の皮膚外用剤基剤ならばいずれのも
のも使用できる。
In the present invention, 4- (1,1-dimethylethyl) -4 '
-Methoxydibenzoylmethane and a monohydric alcohol having a linear, branched or unsaturated alkyl residue having 9 to 31 carbon atoms and an acid having a linear, branched or unsaturated alkyl residue having a carbon atom of 9 to 31 As the skin external preparation base to which the monovalent ester is added, any ordinary skin external preparation base can be used.

すなわち、液状、ゲル状、ペースト状、クリーム状など
のもので、皮膚外用剤を修飾する成分として保湿剤、油
分、界面活性剤、増粘剤、金属封鎖剤、その他の紫外線
吸収剤、薬剤、色素、香料などが併用できることは言う
までもない。
That is, liquids, gels, pastes, creams and the like, as a component for modifying the skin external preparation, moisturizers, oils, surfactants, thickeners, sequestering agents, other ultraviolet absorbers, drugs, It goes without saying that dyes and fragrances can be used in combination.

[実施例] <実施例1>サンスクリーンオイル 4−(1,1−ジメチルエチル) 2wt% −4′−メトキシジベンゾイル メタン グリセリルモノオレート 2 ホホバ油 20 流動パラフィン 76 [発明の効果] 実施例1は本発明にしたがって4−(1,1−ジメチル
エチル)−4′−メトキシジベンゾイルメタンと、炭素
数9ないし31の直鎖、分岐、不飽和アルキル残基を持
つ1価のアルコールと炭素数9ないし31の直鎖、分
岐、不飽和アルキル残基を持つ酸との1価のエステルを
配合した皮膚外用剤である。
[Examples] <Example 1> Sunscreen oil 4- (1,1-dimethylethyl) 2wt% -4'-methoxydibenzoyl methane glyceryl monooleate 2 jojoba oil 20 liquid paraffin 76 [Effect of the invention] Example 1 Is 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane in accordance with the present invention, a monovalent alcohol having a linear, branched or unsaturated alkyl residue having 9 to 31 carbon atoms and a carbon number. A skin external preparation containing a monovalent ester of an acid having a linear, branched or unsaturated alkyl residue of 9 to 31.

一方、4−(1,1−ジメチルエチル)−4′−メトキ
シジベンゾイルメタンを配合しない場合、およびエステ
ルを配合しない場合を対照例として下記に示す。
On the other hand, the case where 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane is not mixed and the case where ester is not mixed are shown below as control examples.

<対照例1> 4−(1,1−ジメチルエチル) 2wt% −4′−メトキシジベンゾイル メタン グリセリルモノオレート 2 流動パラフィン 96 <対照例2> グリセリルモノオレート 2wt% ホホバ油 20 流動パラフィン 78 表1に保存安定性および紫外線防御効果を示す。<Control Example 1> 4- (1,1-dimethylethyl) 2 wt% -4'-methoxydibenzoyl methane glyceryl monooleate 2 liquid paraffin 96 <Control Example 2> glyceryl monooleate 2 wt% jojoba oil 20 liquid paraffin 78 Table 1 Shows storage stability and UV protection effect.

実施例1および対照例1、2の皮膚外用剤はいずれもサ
ンスクリーンオイルとして使用されるものである。
The external preparations for skin of Example 1 and Comparative Examples 1 and 2 are all used as sunscreen oils.

対照例1は製造直後は均一な液状であるものの4−
(1,1−ジメチルエチル)−4′−メトキシジベンゾ
イルメタンが徐々に析出し皮膚外用剤としての品質が劣
化し紫外線防御効果さえも減少してくる。
Although Comparative Example 1 was a uniform liquid immediately after the production, 4-
(1,1-Dimethylethyl) -4'-methoxydibenzoylmethane is gradually deposited, and the quality of the external skin preparation is deteriorated, and even the ultraviolet protection effect is reduced.

対照例2は結晶が析出することはないが紫外線防御効果
については当然期待できない。
In Comparative Example 2, crystals are not precipitated, but the UV protection effect cannot be expected.

これに対し実施例1は、製造直後はもちろん長期間保存
したあとでも結晶が析出することがなく、紫外線防御効
果に優れ、品質が安定している。
On the other hand, in Example 1, the crystals are not precipitated immediately after the production and also after the storage for a long period of time, the ultraviolet protection effect is excellent, and the quality is stable.

これは本発明に係る技術を応用した結果である。This is a result of applying the technique according to the present invention.

次に本発明により多くの実施例で詳述するが本発明はこ
れにより限定されるものではない。
Next, the present invention will be described in detail with reference to a number of examples, but the present invention is not limited thereto.

実施例2 実施例2 A.セタノール 3wt% グリセリルモノステアレート 2 ステアリン酸 3 ワセリン 3 ホホバ油 3 2−ヘキシルデシルミリステート 4 スクワラン 5 4−(1,1−ジメチルエチル) 2 −4′−メトキシジベンゾイル メタン 香料 適量 B.プロピレングリコール 3 水酸化カリウム 0.2 精製水 全体を100とする量 Aの油相部分とBの水相部分をそれぞれ70℃で加熱溶
解し、AをBに加え乳化する。そののち冷却処理をして
クリームを得る。
Example 2 Example 2 A. Cetanol 3 wt% Glyceryl monostearate 2 Stearic acid 3 Vaseline 3 Jojoba oil 3 2-Hexyldecyl myristate 4 Squalane 5 4- (1,1-Dimethylethyl) 2 -4'-methoxydibenzoyl methane fragrance Amount B. Propylene glycol 3 Potassium hydroxide 0.2 Purified water based on the total amount of 100 An oil phase portion of A and an aqueous phase portion of B are dissolved by heating at 70 ° C., and A is added to B to emulsify. Then, it is cooled to obtain a cream.

実施例4 A.ステアリルアルコール 2wt% グリセリルモノステアレート 2 POE(50) オレイルエーテル 2 ステアリン酸 2 精製ラノリン 2 2−ヘプチルウンデシル 2 パルミテート 2−オクチルドデシル−2′− 5 イソヘプチルイソウンデカノエート 4−(1,1−ジメチルエチル) 2 −4′−メトキンジベンゾイル メタン 防腐剤 適量 香料 適量 B.グリセリン 5 水酸化カリウム 0.2 精製水 全体を100とする量 C.調合粉末 10 Aの油相原料、Bの水相原料をそれぞれ70℃で加熱溶
解したのちAをBに加えて乳化する。そのものにCの粉
末部を分散処理しついで冷却処理して、クリーム状ファ
ンデーションを得る。
Example 4 A. Stearyl alcohol 2 wt% glyceryl monostearate 2 POE (50) oleyl ether 2 stearic acid 2 purified lanolin 2 2-heptylundecyl 2 palmitate 2-octyldodecyl-2'-5 isoheptylisoundecanoate 4- (1,1 -Dimethylethyl) 2-4'-methoquindibenzoyl methane Preservative Amount Perfume Amount B. Glycerin 5 Potassium hydroxide 0.2 Purified water 100 as a whole C.I. Formulated powder 10 A oil phase raw material and B aqueous phase raw material are heated and melted at 70 ° C., respectively, and then A is added to B and emulsified. A powdery portion of C is dispersed therein and then cooled to obtain a cream foundation.

実施例5 オレンジラファー油 50wt% ホホバ油 30 流動パラフィン 10 4−(1,1−ジメチルエチル)10 −4′−メトキシジベンゾイル メタン 色素 適量 香料 適量 上記の各成分を50℃で加熱溶解したのち撹拌冷却しボ
ディ用オイルを得る。
Example 5 Orange lafa oil 50 wt% jojoba oil 30 Liquid paraffin 10 4- (1,1-Dimethylethyl) 10-4'-methoxydibenzoyl methane Dye Appropriate amount Perfume Appropriate amount The above components are heated and dissolved at 50 ° C. and then stirred. Cool and get body oil.

実施例6 固形パラフィン 10wt% 流動パラフィン 全量を100とする量 ワセリン 20 グリセリルモノミリステート 10 オレイルオレート 0.05 4−(1,1−ジメチルエチル) 0.1 −4′−メトキシジベンゾイル メタン 色素 適量 香料 適量 上記の各成分を50℃で加熱溶解したのち撹拌冷却しボ
ディ用ゲルを得る。
Example 6 Solid paraffin 10 wt% Liquid paraffin Amount based on the total amount of 100 Vaseline 20 Glyceryl monomyristate 10 Oleyl oleate 0.05 4- (1,1-Dimethylethyl) 0.1 -4'-methoxydibenzoyl methane dye Appropriate amount Fragrance Suitable amount Each of the above components is heated and dissolved at 50 ° C., and then stirred and cooled to obtain a gel for body.

実施例2〜6の皮膚外用剤は紫外線吸収効果に優れ、ま
た製造後3ヶ月経ても結晶の析出による品質の劣化は皆
無であった。
The external preparations for skin of Examples 2 to 6 were excellent in the effect of absorbing ultraviolet rays, and there was no deterioration in quality due to precipitation of crystals even after 3 months from the production.

これは本発明に係る技術を応用した結果である。This is a result of applying the technique according to the present invention.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】4−(1、1−ジメチルエチル)−4′−
メトキシジベンゾイルメタンとともに、炭素数9ないし
31の直鎖、分岐、不飽和アルキル残基を持つ1価のア
ルコールと炭素数9ないし31の直鎖、分岐、不飽和ア
ルキル残基を持つ酸との1価のエステルを配合したこと
を特徴とする皮膚外用剤。
1. 4- (1,1-Dimethylethyl) -4'-
Along with methoxydibenzoylmethane, a monohydric alcohol having a straight-chain, branched, unsaturated alkyl residue having 9 to 31 carbon atoms and an acid having a straight-chain, branched, unsaturated alkyl residue having 9 to 31 carbon atoms A skin external preparation characterized by containing a monovalent ester.
JP60056489A 1985-03-20 1985-03-20 External skin preparation Expired - Lifetime JPH0645531B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60056489A JPH0645531B2 (en) 1985-03-20 1985-03-20 External skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60056489A JPH0645531B2 (en) 1985-03-20 1985-03-20 External skin preparation

Publications (2)

Publication Number Publication Date
JPS61215316A JPS61215316A (en) 1986-09-25
JPH0645531B2 true JPH0645531B2 (en) 1994-06-15

Family

ID=13028507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60056489A Expired - Lifetime JPH0645531B2 (en) 1985-03-20 1985-03-20 External skin preparation

Country Status (1)

Country Link
JP (1) JPH0645531B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925473D0 (en) * 1989-11-10 1989-12-28 Unilever Plc Sunscreen compositions
GB9305316D0 (en) * 1993-03-16 1993-05-05 Unilever Plc Skin emollinets
JP3537622B2 (en) * 1996-02-26 2004-06-14 株式会社資生堂 UV absorbing composition
FR2768730B1 (en) * 1997-09-25 1999-12-31 Jean Noel Thorel PROCESS FOR THE PHOTOSTABILIZATION OF 4- (TER.BUTYL) 4'-METHOXY DIBENZOYLMETHANE, FILTERING COMPOSITIONS THUS OBTAINED AND THEIR USES
TWI414320B (en) * 2004-05-13 2013-11-11 Hisamitsu Pharmaceutical Co A transdermal formulation comprising non-steroid anti-inflammation drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056488A (en) * 1983-09-08 1985-04-02 Kishimoto Akira Method and device for producing welded can body

Also Published As

Publication number Publication date
JPS61215316A (en) 1986-09-25

Similar Documents

Publication Publication Date Title
EP2149361B1 (en) Oil-in-water emulsion composition and method for producing the same
JP2643838B2 (en) Cosmetic or dermatological composition
EP0154928A2 (en) Long wavelength ultraviolet ray absorber
KR101066435B1 (en) Skin preparations for external use
JPH01502116A (en) Moisture resistant skin treatment composition
JPS6058889B2 (en) High internal phase water-in-oil emulsion
JP3894064B2 (en) Oil-based thickening gel composition, emulsified composition using the composition, and preparation method thereof
JP3485375B2 (en) External preparation for skin
JP3582016B2 (en) External preparation for skin
KR900004090B1 (en) Ultraviolet absorbing compositions and sunsrelning agents
WO2003061608A1 (en) Water-in-oil emulsion composition and emulsion cosmetic comprising the same
JPH0645531B2 (en) External skin preparation
JP3261807B2 (en) Gel composition having thixotropy
KR950007906B1 (en) Long wave uv ray absorber and its cosmetics
JP7212634B2 (en) GEL COMPOSITION AND METHOD FOR MANUFACTURING SAME
JPH0645530B2 (en) External skin preparation
JPH09291016A (en) Hair cosmetic material
JPH0532531A (en) Cosmetic
JP2007308386A (en) Water-in-oil emulsion type external preparation for skin
JPS61215311A (en) External agent for skin
JPH03255013A (en) Cosmetic
JPS61215314A (en) External agent for skin
JP2533775B2 (en) Topical skin
JPH01135887A (en) Ultraviolet ray absorber composition
JP3268504B2 (en) Gel composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term